Serge Masson

Title: The Innovative Contributions of Serge Masson

Introduction

Serge Masson is a notable inventor based in Rotkreuz, Switzerland. He has made significant contributions to the field of medical diagnostics, particularly in the area of heart failure. His work focuses on differentiating between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).

Latest Patents

Serge Masson holds a patent for the invention titled "IGFBP7 ratio for HFpEF." This invention relates to a method for diagnosing heart failure by determining the amounts of IGFBP7, a BNP-type peptide, and optionally CRP in a sample from a subject. The method involves calculating specific ratios and comparing them with reference ratios to differentiate between HFpEF and HFrEF. This innovative approach has the potential to improve diagnostic accuracy for patients suffering from heart failure. He has 1 patent to his name.

Career Highlights

Serge Masson is currently employed at Roche Diagnostics Operations, Inc., a leading company in the field of medical diagnostics. His work at Roche has allowed him to contribute to advancements in healthcare technology and improve patient outcomes through innovative diagnostic methods.

Collaborations

Throughout his career, Serge has collaborated with talented professionals, including Kai Habben and Vinzent Rolny. These collaborations have fostered an environment of innovation and have led to the development of impactful medical solutions.

Conclusion

Serge Masson's contributions to the field of heart failure diagnostics exemplify the importance of innovation in medicine. His patented method for differentiating between types of heart failure showcases his commitment to improving patient care through scientific advancements.